ADAM10 may be significant in promoting BrCa progression by proteolytically releasing sCXCL16 and activating oncogenic CXCR6 signaling.
← all excerpts
CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling.
1
—
—
ADAM10 may be significant in promoting BrCa progression by proteolytically releasing sCXCL16 and activating oncogenic CXCR6 signaling.